|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q122887961
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241020232955.0 |
|
008
|
|
|
241020nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q122887961
|
|
024
|
|
|
‡a
7402688911
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q122887961
|
|
043
|
|
|
‡c
DE
|
|
046
|
|
|
‡f
19540519
|
|
100
|
0 |
|
‡a
Heinz-Josef Schmitt
‡c
deutscher Mediziner
‡9
de
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Heinz-Josef Schmitt
‡c
researcher
‡9
en
|
|
670
|
|
|
‡a
Author's Antibodies to pertussis antigens in pediatric health care workers
|
|
670
|
|
|
‡a
Author's Are meteorological parameters associated with acute respiratory tract infections?
|
|
670
|
|
|
‡a
Author's Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical practice in randomized controlled clinical trials
|
|
670
|
|
|
‡a
Author's Booster vaccination after neonatal priming with acellular pertussis vaccine
|
|
670
|
|
|
‡a
Author's Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review
|
|
670
|
|
|
‡a
Author's Can respiratory syncytial virus etiology be diagnosed clinically? A hospital-based case-control study in children under two years of age.
|
|
670
|
|
|
‡a
Author's Chapter 14: HPV vaccine introduction in industrialized countries
|
|
670
|
|
|
‡a
Author's Consequences of delayed measles vaccination in Germany.
|
|
670
|
|
|
‡a
Author's Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-Analysis of Observational Studies
|
|
670
|
|
|
‡a
Author's Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure
|
|
670
|
|
|
‡a
Author's Effectiveness of measles vaccination after household exposure during a measles outbreak: a household contact study in Coburg, Bavaria
|
|
670
|
|
|
‡a
Author's Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies
|
|
670
|
|
|
‡a
Author's Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats
|
|
670
|
|
|
‡a
Author's Evolving role of 13-valent pneumococcal conjugate vaccine in clinical practice
|
|
670
|
|
|
‡a
Author's Four and One-Half-Year Follow-up of the Effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b and Diphtheria-Tetanus Toxoids-Acellular Pertussis-Inactivated Poliovirus/H. influenzae Type b Combination Vaccines
|
|
670
|
|
|
‡a
Author's Immunisation status of children in Germany: temporal trends and regional differences
|
|
670
|
|
|
‡a
Author's Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
|
|
670
|
|
|
‡a
Author's Invasive nontypeable Haemophilus influenzae infections in Germany: a case report of a previously healthy 7-year-old boy with an intracranial abscess, and epidemiological data from 2001 to 2004.
|
|
670
|
|
|
‡a
Author's Oil-in-water emulsion adjuvant with influenza vaccine in young children
|
|
670
|
|
|
‡a
Author's Pertussis: Microbiology, Disease, Treatment, and Prevention
|
|
670
|
|
|
‡a
Author's Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology
|
|
670
|
|
|
‡a
Author's Pneumococcal serotype evolution in Western Europe
|
|
670
|
|
|
‡a
Author's Population-based burden of pneumonia before school entry in Schleswig-Holstein, Germany
|
|
670
|
|
|
‡a
Author's [Prion safety of medicinal products using the example of an influenza vaccine produced in a cell line]
|
|
670
|
|
|
‡a
Author's Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis
|
|
670
|
|
|
‡a
Author's Review of 8 years of experience with Infanrix hexa
|
|
670
|
|
|
‡a
Author's Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).
|
|
670
|
|
|
‡a
Author's Safety of cell culture-based influenza vaccines
|
|
670
|
|
|
‡a
Author's Safety of MDCK cell culture-based influenza vaccines
|
|
670
|
|
|
‡a
Author's Self-reported tick-borne encephalitis
|
|
670
|
|
|
‡a
Author's Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study.
|
|
670
|
|
|
‡a
Author's Serotype evolution in Western Europe: perspectives on invasive pneumococcal diseases (IPD)
|
|
670
|
|
|
‡a
Author's Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.
|
|
670
|
|
|
‡a
Author's Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children
|
|
670
|
|
|
‡a
Author's The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage
|
|
670
|
|
|
‡a
Author's The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review
|
|
670
|
|
|
‡a
Author's The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion
|
|
670
|
|
|
‡a
Author's The use of combination vaccines has improved timeliness of vaccination in children
|
|
670
|
|
|
‡a
Author's Tick-borne encephalitis: A 43-year summary of epidemiological and clinical data from Latvia
|
|
670
|
|
|
‡a
Author's Tick-borne encephalitis: A 43-year summary of epidemiological and clinical data from Latvia (1973 to 2016)
|
|
670
|
|
|
‡a
Author's Tick-borne encephalitis in China: A review of epidemiology and vaccines
|
|
670
|
|
|
‡a
Author's Tick-borne encephalitis in Japan, Republic of Korea and China
|
|
670
|
|
|
‡a
Author's [Vaccinations in childhood: needle sticks at the beginning of life for a healthy future]
|
|
670
|
|
|
‡a
Author's What can children gain from pneumococcal conjugate vaccines?
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/DNB|1013374975
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/281624655
|
|
909
|
|
|
‡a
(scopus) 7402688911
‡9
1
|
|
919
|
|
|
‡a
potentialforpneumococcalvaccinationinhajjpilgrimsexpertopinion
‡A
The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion
‡9
1
|
|
919
|
|
|
‡a
impactofroutinechildhoodimmunizationwithhighervalentpneumococcalconjugatevaccinesonantimicrobialresistantpneumococcaldiseasesandcarriageasystematicliteraturereview
‡A
The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review
‡9
1
|
|
919
|
|
|
‡a
impactofpneumococcalconjugatevaccinesonserotype19anasopharyngealcarriage
‡A
The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage
‡9
1
|
|
919
|
|
|
‡a
10yearsexperiencewithyearroundactivesurveillanceofupto19respiratorypathogensinchildren
‡A
Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children
‡9
1
|
|
919
|
|
|
‡a
shouldhealthychildrenbevaccinatedagainstinfluenzaaconsensusreportofthesummitsofindependenteuropeanvaccinationexperts
‡A
Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.
‡9
1
|
|
919
|
|
|
‡a
serotypeevolutioninwesterneuropeperspectivesoninvasivepneumococcaldiseasesipd
‡A
Serotype evolution in Western Europe: perspectives on invasive pneumococcal diseases (IPD)
‡9
1
|
|
919
|
|
|
‡a
selfreportedtickborneencephalitistbevaccinationcoverageineuroperesultsfromacrosssectionalstudy
‡A
Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study.
‡9
1
|
|
919
|
|
|
‡a
selfreportedtickborneencephalitis
‡A
Self-reported tick-borne encephalitis
‡9
1
|
|
919
|
|
|
‡a
safetyofmdckcellculturebasedinfluenzavaccines
‡A
Safety of MDCK cell culture-based influenza vaccines
‡9
1
|
|
919
|
|
|
‡a
safetyofcellculturebasedinfluenzavaccines
‡A
Safety of cell culture-based influenza vaccines
‡9
1
|
|
919
|
|
|
‡a
reviewof8yearsofexperiencewithinfanrixhexadtpahbvipvhibhexavalentvaccine
‡A
Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).
‡9
1
|
|
919
|
|
|
‡a
reviewof8yearsofexperiencewithinfanrixhexa
‡A
Review of 8 years of experience with Infanrix hexa
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusassociatedhospitalizationratesamongusinfantsasystematicreviewandmetaanalysis
‡A
Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis
‡9
1
|
|
919
|
|
|
‡a
prionsafetyofmedicinalproductsusingtheexampleofaninfluenzavaccineproducedinacellline
‡A
[Prion safety of medicinal products using the example of an influenza vaccine produced in a cell line]
‡9
1
|
|
919
|
|
|
‡a
populationbasedburdenofpneumoniabeforeschoolentryinschleswigholsteingermany
‡A
Population-based burden of pneumonia before school entry in Schleswig-Holstein, Germany
‡9
1
|
|
919
|
|
|
‡a
pneumococcalserotypeevolutioninwesterneurope
‡A
Pneumococcal serotype evolution in Western Europe
‡9
1
|
|
919
|
|
|
‡a
tickborneencephalitisa43yearsummaryofepidemiologicalandclinicaldatafromlatvia1973to
‡A
Tick-borne encephalitis: A 43-year summary of epidemiological and clinical data from Latvia (1973 to 2016)
‡9
1
|
|
919
|
|
|
‡a
tickborneencephalitisinchinaareviewofepidemiologyandvaccines
‡A
Tick-borne encephalitis in China: A review of epidemiology and vaccines
‡9
1
|
|
919
|
|
|
‡a
tickborneencephalitisinjapanrepublicofkoreaandchina
‡A
Tick-borne encephalitis in Japan, Republic of Korea and China
‡9
1
|
|
919
|
|
|
‡a
vaccinationsinchildhoodneedlesticksatthebeginningoflifeforahealthyfuture
‡A
[Vaccinations in childhood: needle sticks at the beginning of life for a healthy future]
‡9
1
|
|
919
|
|
|
‡a
whatcanchildrengainfrompneumococcalconjugatevaccines
‡A
What can children gain from pneumococcal conjugate vaccines?
‡9
1
|
|
919
|
|
|
‡a
pneumococcalempyemaandcomplicatedpneumoniasglobaltrendsinincidenceprevalenceandserotypeepidemiology
‡A
Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology
‡9
1
|
|
919
|
|
|
‡a
pertussismicrobiologydiseasetreatmentandprevention
‡A
Pertussis: Microbiology, Disease, Treatment, and Prevention
‡9
1
|
|
919
|
|
|
‡a
oilinwateremulsionadjuvantwithinfluenzavaccineinyoungchildren
‡A
Oil-in-water emulsion adjuvant with influenza vaccine in young children
‡9
1
|
|
919
|
|
|
‡a
invasivenontypeablehaemophilusinfluenzaeinfectionsingermanyacasereportofapreviouslyhealthy7yearoldboywithanintracranialabscessandepidemiologicaldatafrom2001to
‡A
Invasive nontypeable Haemophilus influenzae infections in Germany: a case report of a previously healthy 7-year-old boy with an intracranial abscess, and epidemiological data from 2001 to 2004.
‡9
1
|
|
919
|
|
|
‡a
influenzavaccineconcurrentlyadministeredwithacombinationmeaslesmumpsandrubellavaccinetoyoungchildren
‡A
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
‡9
1
|
|
919
|
|
|
‡a
immunisationstatusofchildreningermanytemporaltrendsandregionaldifferences
‡A
Immunisation status of children in Germany: temporal trends and regional differences
‡9
1
|
|
919
|
|
|
‡a
4and1halfyearfollowupoftheeffectivenessofdiphtheriatetanustoxoidsacellularpertussishaemophilusinfluenzaetypebanddiphtheriatetanustoxoidsacellularpertussisinactivatedpoliovirushinfluenzaetypebcombinationvaccines
‡A
Four and One-Half-Year Follow-up of the Effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b and Diphtheria-Tetanus Toxoids-Acellular Pertussis-Inactivated Poliovirus/H. influenzae Type b Combination Vaccines
‡9
1
|
|
919
|
|
|
‡a
evolvingroleof13valentpneumococcalconjugatevaccineinclinicalpractice
‡A
Evolving role of 13-valent pneumococcal conjugate vaccine in clinical practice
‡9
1
|
|
919
|
|
|
‡a
efficacyofposaconazoleandamphotericinbinexperimentalinvasivepulmonaryaspergillosisindexamethasoneimmunosuppressedrats
‡A
Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats
‡9
1
|
|
919
|
|
|
‡a
effectivenessofpneumococcalvaccinesinpreventingpneumoniainadultsasystematicreviewandmetaanalysesofobservationalstudies
‡A
Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies
‡9
1
|
|
919
|
|
|
‡a
effectivenessofmeaslesvaccinationafterhouseholdexposureduringameaslesoutbreakahouseholdcontactstudyincoburgbavaria
‡A
Effectiveness of measles vaccination after household exposure during a measles outbreak: a household contact study in Coburg, Bavaria
‡9
1
|
|
919
|
|
|
‡a
effectivenessofhexavalentvaccinesagainstinvasivehaemophilusinfluenzaetypebdiseasegermanysexperienceafter5yearsoflicensure
‡A
Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure
‡9
1
|
|
919
|
|
|
‡a
effectivenessof13valentpneumococcalconjugatevaccineagainstinvasivediseasecausedbyserotype3inchildrenasystematicreviewandmetaanalysisofobservationalstudies
‡A
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-Analysis of Observational Studies
‡9
1
|
|
919
|
|
|
‡a
consequencesofdelayedmeaslesvaccinationingermany
‡A
Consequences of delayed measles vaccination in Germany.
‡9
1
|
|
919
|
|
|
‡a
chapter14hpvvaccineintroductioninindustrializedcountries
‡A
Chapter 14: HPV vaccine introduction in industrialized countries
‡9
1
|
|
919
|
|
|
‡a
canrespiratorysyncytialvirusetiologybediagnosedclinicallyahospitalbasedcasecontrolstudyinchildrenunder2yearsofage
‡A
Can respiratory syncytial virus etiology be diagnosed clinically? A hospital-based case-control study in children under two years of age.
‡9
1
|
|
919
|
|
|
‡a
burdenofpneumococcalcommunityacquiredpneumoniainadultsacrosseuropealiteraturereview
‡A
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review
‡9
1
|
|
919
|
|
|
‡a
boostervaccinationafterneonatalprimingwithacellularpertussisvaccine
‡A
Booster vaccination after neonatal priming with acellular pertussis vaccine
‡9
1
|
|
919
|
|
|
‡a
assessingvaccineefficacyforthepreventionofacuteotitismediabypneumococcalvaccinationinchildrenamethodologicaloverviewofstatisticalpracticeinrandomizedcontrolledclinicaltrials
‡A
Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical practice in randomized controlled clinical trials
‡9
1
|
|
919
|
|
|
‡a
aremeteorologicalparametersassociatedwithacuterespiratorytractinfections
‡A
Are meteorological parameters associated with acute respiratory tract infections?
‡9
1
|
|
919
|
|
|
‡a
antibodiestopertussisantigensinpediatrichealthcareworkers
‡A
Antibodies to pertussis antigens in pediatric health care workers
‡9
1
|
|
919
|
|
|
‡a
tickborneencephalitisa43yearsummaryofepidemiologicalandclinicaldatafromlatvia
‡A
Tick-borne encephalitis: A 43-year summary of epidemiological and clinical data from Latvia
‡9
1
|
|
919
|
|
|
‡a
useofcombinationvaccineshasimprovedtimelinessofvaccinationinchildren
‡A
The use of combination vaccines has improved timeliness of vaccination in children
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2016
‡9
1
|
|
943
|
|
|
‡a
200x
‡A
2004
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
947
|
|
|
‡a
DE
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000073369141
|
|
996
|
|
|
‡2
NUKAT|n 2012244917
|
|
996
|
|
|
‡2
ISNI|0000000425467758
|
|
996
|
|
|
‡2
DNB|1316712761
|
|
996
|
|
|
‡2
BIBSYS|90554615
|
|
996
|
|
|
‡2
BIBSYS|90247468
|
|
996
|
|
|
‡2
ISNI|0000000014884557
|
|
996
|
|
|
‡2
DNB|1027354963
|
|
996
|
|
|
‡2
NSK|000732755
|
|
996
|
|
|
‡2
NUKAT|n 2011214029
|
|
996
|
|
|
‡2
NUKAT|n 2019011813
|
|
996
|
|
|
‡2
BIBSYS|3042393
|
|
996
|
|
|
‡2
DNB|1053164149
|
|
996
|
|
|
‡2
BIBSYS|90156355
|
|
996
|
|
|
‡2
PLWABN|9810642961405606
|
|
996
|
|
|
‡2
NTA|067754767
|
|
996
|
|
|
‡2
NII|DA0611858X
|
|
996
|
|
|
‡2
RERO|A003801776
|
|
996
|
|
|
‡2
NUKAT|n 2021007956
|
|
996
|
|
|
‡2
DNB|1153565668
|
|
996
|
|
|
‡2
ISNI|0000000459505783
|
|
996
|
|
|
‡2
DE633|pe318528
|
|
996
|
|
|
‡2
NII|DA02273649
|
|
996
|
|
|
‡2
J9U|987007367052805171
|
|
996
|
|
|
‡2
DNB|1139222538
|
|
996
|
|
|
‡2
NUKAT|n 2008104571
|
|
996
|
|
|
‡2
PLWABN|9810647586905606
|
|
996
|
|
|
‡2
BNF|12449060
|
|
996
|
|
|
‡2
RERO|A003801794
|
|
996
|
|
|
‡2
RERO|A005616165
|
|
996
|
|
|
‡2
DNB|108814394
|
|
996
|
|
|
‡2
LC|no 97042760
|
|
996
|
|
|
‡2
NTA|11990313X
|
|
996
|
|
|
‡2
ISNI|0000000489182938
|
|
996
|
|
|
‡2
LIH|LNB:DD_j_2;=BK
|
|
996
|
|
|
‡2
PLWABN|9810633578005606
|
|
996
|
|
|
‡2
SUDOC|231683200
|
|
996
|
|
|
‡2
RERO|A022401453
|
|
996
|
|
|
‡2
NII|DA04976060
|
|
996
|
|
|
‡2
NKC|ola2003186183
|
|
996
|
|
|
‡2
NUKAT|n 2012265219
|
|
996
|
|
|
‡2
DNB|1203452683
|
|
996
|
|
|
‡2
SUDOC|116280530
|
|
996
|
|
|
‡2
PLWABN|9810558667705606
|
|
996
|
|
|
‡2
DNB|1204937532
|
|
996
|
|
|
‡2
BAV|495_337236
|
|
996
|
|
|
‡2
RERO|A003801791
|
|
996
|
|
|
‡2
RERO|A003801797
|
|
996
|
|
|
‡2
NII|DA0860173X
|
|
996
|
|
|
‡2
PLWABN|9810623507805606
|
|
996
|
|
|
‡2
DNB|129078751
|
|
996
|
|
|
‡2
DE633|pe30106641
|
|
996
|
|
|
‡2
DNB|1079561161
|
|
996
|
|
|
‡2
ISNI|000000002491043X
|
|
996
|
|
|
‡2
NUKAT|n 2015144542
|
|
996
|
|
|
‡2
PTBNP|1894353
|
|
996
|
|
|
‡2
BNE|XX834993
|
|
996
|
|
|
‡2
SUDOC|027127109
|
|
996
|
|
|
‡2
BIBSYS|13008313
|
|
996
|
|
|
‡2
ISNI|0000000067908436
|
|
996
|
|
|
‡2
LC|n 79042289
|
|
996
|
|
|
‡2
ISNI|0000000408297785
|
|
996
|
|
|
‡2
BNCHL|10000000000000000060238
|
|
996
|
|
|
‡2
ISNI|0000000408509944
|
|
996
|
|
|
‡2
LC|no2009198543
|
|
996
|
|
|
‡2
BIBSYS|90321139
|
|
996
|
|
|
‡2
NTA|23978961X
|
|
996
|
|
|
‡2
DNB|124559875
|
|
996
|
|
|
‡2
BIBSYS|1006866
|
|
996
|
|
|
‡2
BAV|495_161939
|
|
996
|
|
|
‡2
DNB|173956025
|
|
996
|
|
|
‡2
NTA|069645523
|
|
996
|
|
|
‡2
ISNI|0000000409191536
|
|
996
|
|
|
‡2
PLWABN|9810591844505606
|
|
996
|
|
|
‡2
BIBSYS|90136751
|
|
996
|
|
|
‡2
BNF|11924043
|
|
996
|
|
|
‡2
NTA|087698714
|
|
996
|
|
|
‡2
DNB|1013374975
|
|
996
|
|
|
‡2
ISNI|0000000066494710
|
|
996
|
|
|
‡2
DNB|173041086
|
|
996
|
|
|
‡2
LC|nr 92027989
|
|
996
|
|
|
‡2
SUDOC|195812417
|
|
996
|
|
|
‡2
BIBSYS|90822621
|
|
997
|
|
|
‡a
1954 0 lived 0519 0
‡9
1
|
|
998
|
|
|
‡a
Schmitt, Heinz-Josef
‡2
DNB|1013374975
‡3
suggested
|
|
998
|
|
|
‡a
Schmitt, Heinz-Josef.
‡2
NUKAT|n 2019011813
‡3
viafid
|
|
998
|
|
|
‡a
Schmitt, Heinz-J.
‡2
BIBSYS|1006866
‡3
viafid
|
